"Multiple Sclerosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
Descriptor ID |
D009103
|
MeSH Number(s) |
C10.114.375.500 C10.314.350.500 C20.111.258.250.500
|
Concept/Terms |
Multiple Sclerosis- Multiple Sclerosis
- Sclerosis, Multiple
- Sclerosis, Disseminated
- Disseminated Sclerosis
- MS (Multiple Sclerosis)
|
Below are MeSH descriptors whose meaning is more general than "Multiple Sclerosis".
Below are MeSH descriptors whose meaning is more specific than "Multiple Sclerosis".
This graph shows the total number of publications written about "Multiple Sclerosis" by people in this website by year, and whether "Multiple Sclerosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1998 | 3 | 2 | 5 |
1999 | 4 | 0 | 4 |
2000 | 4 | 3 | 7 |
2001 | 8 | 1 | 9 |
2002 | 8 | 1 | 9 |
2003 | 10 | 1 | 11 |
2004 | 10 | 1 | 11 |
2005 | 11 | 1 | 12 |
2006 | 2 | 0 | 2 |
2007 | 6 | 1 | 7 |
2008 | 6 | 0 | 6 |
2009 | 8 | 2 | 10 |
2010 | 6 | 0 | 6 |
2011 | 6 | 3 | 9 |
2012 | 7 | 1 | 8 |
2013 | 9 | 1 | 10 |
2014 | 10 | 0 | 10 |
2015 | 4 | 1 | 5 |
2016 | 5 | 0 | 5 |
2017 | 10 | 2 | 12 |
2018 | 4 | 2 | 6 |
2019 | 7 | 1 | 8 |
2020 | 15 | 2 | 17 |
2021 | 14 | 1 | 15 |
2022 | 14 | 0 | 14 |
2023 | 11 | 0 | 11 |
2024 | 13 | 3 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Multiple Sclerosis" by people in Profiles.
-
Association of Social Determinants of Health With Brain MRI Outcomes in Individuals With Pediatric Onset Multiple Sclerosis. Neurology. 2024 Dec 24; 103(12):e210140.
-
Comparative effectiveness of high-efficacy and moderate efficacy disease-modifying agents in reducing the annualized relapse rates among multiple sclerosis patients in the United States. Prev Med. 2025 Jan; 190:108180.
-
Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States. Neurology. 2024 Dec 10; 103(11):e209991.
-
Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia. Lancet Neurol. 2024 Oct; 23(10):1050-1062.
-
Factors associated with the initiation of high-efficacy disease-modifying agents over moderate-efficacy disease-modifying agents in multiple sclerosis. Mult Scler Relat Disord. 2024 Nov; 91:105896.
-
Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosis. Mult Scler. 2024 Oct; 30(11-12):1525-1543.
-
Pipe dream: Remyelination therapy for multiple sclerosis. Proc Natl Acad Sci U S A. 2024 Aug 27; 121(35):e2414324121.
-
Nurturing Longitudinal Samples 2.0. West J Nurs Res. 2024 Oct; 46(10):831-836.
-
Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study. Neurol Neuroimmunol Neuroinflamm. 2024 Sep; 11(5):e200282.
-
Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis. Mult Scler. 2024 Jul; 30(8):1056-1065.